Correlation Between NYSE Composite and Neurosense Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Neurosense Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Neurosense Therapeutics.
Diversification Opportunities for NYSE Composite and Neurosense Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Neurosense is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Neurosense Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Neurosense Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 2.74 times less return on investment than Neurosense Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 8.82 times less risky than Neurosense Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Neurosense Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 157.00 in Neurosense Therapeutics on October 21, 2024 and sell it today you would lose (48.00) from holding Neurosense Therapeutics or give up 30.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Neurosense Therapeutics
Performance |
| Timeline |
NYSE Composite and Neurosense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Neurosense Therapeutics
Pair trading matchups for Neurosense Therapeutics
Pair Trading with NYSE Composite and Neurosense Therapeutics
The main advantage of trading using opposite NYSE Composite and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.| NYSE Composite vs. Chart Industries | NYSE Composite vs. Valneva SE ADR | NYSE Composite vs. Schweiter Technologies AG | NYSE Composite vs. Primoris Services |
| Neurosense Therapeutics vs. Quoin Pharmaceuticals Ltd | Neurosense Therapeutics vs. Revelation Biosciences | Neurosense Therapeutics vs. Virax Biolabs Group | Neurosense Therapeutics vs. Nutriband |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |